Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first761 to 780 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| FLT3LG fms related receptor tyrosine kinase 3 ligand | 2323 HGNC:3766 | 1 | 200 | 0 | 0 | 6,808 | 9,500 |
| TAFAZZIN tafazzin, phospholipid-lysophospholipid transacylase | 6901 HGNC:11577 | 1 | 15 | 0 | 0 | 4,484 | 9,500 |
| GIP gastric inhibitory polypeptide | 2695 HGNC:4270 | 1 | 125 | 0 | 0 | 2,456 | 9,497 |
| RENBP renin binding protein | 5973 HGNC:9959 | 1 | 14 | 0 | 0 | 2,717 | 9,495 |
| CDX2 caudal type homeobox 2 | 1045 HGNC:1806 | 1 | 23 | 0 | 0 | 2,866 | 9,492 |
| NR1H4 nuclear receptor subfamily 1 group H member 4 | 9971 HGNC:7967 | 1 | 19 | 9 | 139 | 3,786 | 9,488 |
| ADAM17 ADAM metallopeptidase domain 17 | 6868 HGNC:195 | 1 | 118 | 1 | 1 | 4,789 | 9,480 |
| FTO FTO alpha-ketoglutarate dependent dioxygenase | 79068 HGNC:24678 | 1 | 49 | 1 | 3 | 4,636 | 9,476 |
| LRRK2 leucine rich repeat kinase 2 | 120892 HGNC:18618 | 1 | 38 | 0 | 0 | 3,741 | 9,466 |
| CLU clusterin | 1191 HGNC:2095 | 1 | 221 | 2 | 9 | 5,591 | 9,461 |
| CCR4 C-C motif chemokine receptor 4 | 1233 HGNC:1605 | 1 | 195 | 1 | 31 | 4,922 | 9,456 |
| IGHG3 immunoglobulin heavy constant gamma 3 (G3m marker) | 3502 HGNC:5527 | 1 | 9 | 0 | 0 | 4,036 | 9,442 |
| CBLL2 Cbl proto-oncogene like 2 | 158506 HGNC:26371 | 1 | 23 | 0 | 0 | 5,645 | 9,440 |
| NKX2-1 NK2 homeobox 1 | 7080 HGNC:11825 | 1 | 69 | 0 | 0 | 3,374 | 9,399 |
| KRT14 keratin 14 | 3861 HGNC:6416 | 1 | 30 | 0 | 0 | 4,903 | 9,382 |
| ALDH1A1 aldehyde dehydrogenase 1 family member A1 | 216 HGNC:402 | 1 | 91 | 0 | 0 | 4,093 | 9,378 |
| TEK TEK receptor tyrosine kinase | 7010 HGNC:11724 | 1 | 88 | 8 | 362 | 5,155 | 9,371 |
| GNAS GNAS complex locus | 2778 HGNC:4392 | 4 | 150 | 0 | 0 | 4,626 | 9,367 |
| GDF15 growth differentiation factor 15 | 9518 HGNC:30142 | 1 | 214 | 0 | 0 | 3,929 | 9,318 |
| LCK LCK proto-oncogene, Src family tyrosine kinase | 3932 HGNC:6524 | 1 | 80 | 8 | 436 | 5,719 | 9,309 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=39
{
"data": {
"total": 193990,
"results": [
{
"id": "2323",
"title": "FLT3LG: fms related receptor tyrosine kinase 3 ligand",
"summary": "NCBI Gene 2323. 1 protein, 200 patents, 0 drugs, 0 trials, 6,808 NIH grants and 9,500 papers.",
"record": "/library/genes/2323",
"gene_id": 2323,
"symbol": "FLT3LG",
"name": "fms related receptor tyrosine kinase 3 ligand",
"hgnc_id": "HGNC:3766",
"counts": {
"proteins": 1,
"patents": 200,
"drugs": 0,
"trials": 0,
"grants": 6808,
"papers": 9500
}
},
{
"id": "6901",
"title": "TAFAZZIN: tafazzin, phospholipid-lysophospholipid transacylase",
"summary": "NCBI Gene 6901. 1 protein, 15 patents, 0 drugs, 0 trials, 4,484 NIH grants and 9,500 papers.",
"record": "/library/genes/6901",
"gene_id": 6901,
"symbol": "TAFAZZIN",
"name": "tafazzin, phospholipid-lysophospholipid transacylase",
"hgnc_id": "HGNC:11577",
"counts": {
"proteins": 1,
"patents": 15,
"drugs": 0,
"trials": 0,
"grants": 4484,
"papers": 9500
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=40",
"request_id": "SaRNlybqQohbTW8y"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant